CCAAT/enhancer-binding protein α (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein

Genes and Development

Volumn 10, Issue 7, 1996, Pages 804-815

  Timchenko, Nikolai A ^a   Wilde, Margie ^a   Nakanishi, Makoto ^a   Smith, James R ^a   Darlington, Gretchen J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

C EBP ; Growth inhibition; p21 (WAF 1 CIP 1 SDI 1); Protein stabilization

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CYCLIN DEPENDENT KINASE; CYCLINE; CYCLOHEXIMIDE; DNA BINDING PROTEIN; ENHANCER BINDING FACTOR; MESSENGER RNA; PROTEIN P21; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENHANCER REGION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN STABILITY; REGULATORY MECHANISM; REPRESSOR GENE;

BASE SEQUENCE; BETA-GALACTOSIDASE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIVISION; CLONING, MOLECULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOPROPYL THIOGALACTOSIDE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECOMBINANT PROTEINS; RNA, ANTISENSE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029976068     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.7.804     Document Type: Article

References (42)

1. Birkenmeier, E.H., B. Gwynn, S. Howard, J. Jerry, J.I. Gordon, W.H. Landschulz, and S.L. McKnight. 1989. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes & Dev. 3: 1146-1156.
2. Calkhoven, C.F., P.R.J. Bouwman, L. Snippe, and A.B. Geert. 1994. Translation start site multiplicity of the CCAAT/enhancer binding protein α mRNA is dictated by a small 5′ open reading frame. Nucleic Acids Res. 22(25): 5540-5547.
3. Cao, Z., R.M. Umek, and S.L. McKnight. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes &. Dev. 5: 1538-1552.
4. Diehl, A.M., and S.Q. Yang. 1993. Regenerative changes in C/EBPα and C/EBPβ expression modulate binding to the C/EBP site in the c-fos promoter. Hepatology 19: 447-456.
5. Diehl, A.M., P. Michaelson, and S.Q. Yang. 1994. Selective induction of CCAAT/enhancer binding protein isoforms occurs during rat liver development. Gastroenterology 106: 1625-1637.
6. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzier, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75(4): 817-825.
7. Freytag, S.O. and T.J. Geddes. 1992. Reciprocal regulation of adipogenesis by Myc and C/EBPα. Science 256(5055): 379-382.
8. Freytag, S.O., D.L. Paielli, and J.D. Gilbert. 1994. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes & Dev. 8: 1654-1663.
9. Friedman, A.D. and S.L. McKnight. 1990. Identification of two polypeptide segments of CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin gene. Genes &. Dev. 4: 1416-1426.
10. Friedman, A.D., W.H. Landschulz, and S.L. McKnight. 1989. CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes & Dev. 3: 1314-1322.
11. Gorman, C.M., L.F. Moffat, and B.H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044-1052.
12. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
13. Harper, J W., G R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
14. Hendricks-Taylor, L.R. and G.J. Darlington. 1995. Inhibition of cell proliferation by C/EBPα occurs in many cell types, does not require the presence of p53 or Rb, and is not effected by large T-antigen. Nucleic Acids Res. 23(22): 4726-4733.
15. Jiang, H., J. Lin, Z. Su, F.R. Collart, E. Huberman, and P.B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF/CIP1, expression in the absence of p53. Oncogene 9(11): 3397-3406.
16. Juan, T.S., D.R. Wilson, M.D. Wilde, and G.J. Darlington 1993. Participation of the transcription factor C/EBP delta in the acute phase regulation of the human gene for complement component C3. Proc. Natl. Acad. Sci. 90: 2584-2588.
17. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 223: 680-685.
18. Landschulz, W.H., P.F. Johnson, E.Y. Adashi, B.J. Graves, S.L McKnight. 1988a. Isolation of a recombinant copy of the gene encoding C/EBP. Genes &. Dev. 2: 786-800.
19. Landschulz, W.H., P.F. Johnson, and S.L. McKnight. 1988b. The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science 240: 1759-1764
20. Landschulz, W.H., P.F. Jonson, and S.L. McKnight. 1989. The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science 243: 1681-1688.
21. Legraverend, K , P. Antonson, P. Flodby, and K.G. Xanthopoulos. 1993. High level activity of the mouse CCAAT/enhancer binding protein (C/EBPα) gene promoter involves autoregulation and several ubiquitous transcription factors. Nucleic Acids Res. 21(8): 1735-1742.
22. Li, C.Y., L. Suardet, and J.B. Little. 1995. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem. 270(10): 4971-4974.
23. Lin, F.T. and M.D. Lane. 1992. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes & Dev. 6(4): 533-544.
24. _. 1994. CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. 91: 8757-8761
25. Lin, F.T., O.A. MacDougald, A.M. Diehl, and M.D. Lane. 1993. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha messages: Transcriptional activator lacking antimitotic activity. Proc. Natl. Acad. Sci. 90: 9606-9610.
26. Macleod, K.F., N Sherry, G Hannon, D. Beach, T. Tokino, K. Kanzler, B. Vogelstein, and T. Jacks 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes & Dev 9: 935-944.
27. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes & Dev. 9: 650-662
28. McKnight, S.L., M.D. Lane, and S. Glueckshon-Waelch. 1989. Is C/EBP a central regulator of energy metabolism? Genes & Dev 3: 2021-2024.
29. Mischoulon, D., B. Rana, N.L. Bucher, and S.R. Farmer. 1992. Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBPα) gene expression during hepatocyte proliferation in the regenerating liver and in culture. Mol. Cell. Biol. 12(6): 2553-2560.
30. sdi1 antisense RNA. Proc. Natl. Acad. Sci. 92: 4352-4356.
31. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res 211: 90-98.
32. Ossipow, V., P. Descombes, and U. Schibler. 1993. CCAAT/enhancer binding protein mRNA is translated into multiple protein with different transcription activation potentials. Proc. Natl. Acad Sci. 90: 8219-8223.
33. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
34. INK4. Science 267: 249-252.
35. 1 cyclin-dependent kinases. Genes &. Dev 9: 1149-1163.
36. Timchenko, N., D.R. Wilson, L.R. Taylor, A.M. Wilde, S. Abdelsayed, M. Sawadogo, and G.J. Darlington. 1995. Autoregulation of the human C/EBPα gene by stimulation of upstream stimulatory factor binding. Mol. Cell. Biol. 15(3): 1192-1202.
37. Umek, R.M., A.D. Fnedman, and S.L. McKnight. 1991. CCAAT-enhancer binding protein: A component of a differentiation switch. Science 251: 288-292.
38. Wang, N.D., M J. Finegold, A. Bradley, C.N. Ou, S.V. Abdelsayed, M.D. Wilde, L.R. Taylor, D.R. Wilson, and G.J. Darlington. 1995. Impaired energy homeostasis in C/EBP alpha knock-out mice. Science 269: 1108-1112.
39. Williams, S.C., C.A. Cantwell, and P.F. Johnson. 1991. A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes & Dev 5: 1553-1567.
40. Wilson, D.R., T.S. Juan, M.D. Wilde, G.H. Fey, and G.J. Darlington. 1990. A 58-base-pair region of the human C3 gene confers synergistic inducibility by interleukin-1 and interleukin-6. Mol. Cell. Biol. 10: 6181-6191.
41. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
42. Yeh, W.C., Z. Cao, M. Classon, and S.L. McKnight. 1995. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes & Dev. 9: 168-181.